Physician profile
Hao Tran
NPI 1891997078
$146,831.09
in general payments reported to CMS, 2019-2025
22 companies · $15K in 2025
The $15K reported for 2025 was more than what 81% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,107 · 2020: $11K · 2021: $8,541 · 2022: $13K · 2023: $42K · 2024: $49K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $47K · Consulting Fee: $23K · Travel and Lodging: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $7,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $47,150.00 |
| Consulting Fee | $22,800.00 |
| Travel and Lodging | $14,582.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,862.50 |
| Food and Beverage | $7,862.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $71,824.78 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Abiomed | $71,307.17 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $668.83 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $509.92 | 2023-2024 | Optimizer, Optimizer |
| Boston Scientific Corporation | $407.41 | 2019-2024 | |
| Kestra Medical Technology Services, INC. | $392.06 | 2022-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $383.74 | 2023-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $300.27 | 2019-2025 | Lifevest |
| Getinge USA Sales, LLC | $161.29 | 2023-2024 | Cardiohelp |
| Scpharmaceuticals INC. | $154.18 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $142.95 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $140.77 | 2024-2025 | Wainua, Farxiga |
| Cvrx, INC. | $100.65 | 2023 | Barostim Neo System |
| Endotronix, INC. | $64.65 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $62.87 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $49.88 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $42.09 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $41.95 | 2023-2024 | Inpefa |
| United Therapeutics Corporation | $29.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $18.55 | 2019 | |
| Pfizer INC. | $15.12 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hao Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.